GIMVWe have just finished another Due Diligence assignment commissioned by GIMV. Our job was to assess the lead project and unique delivery technology of a European biopharmaceutical company. We have evaluated their preclinical pharmacology, pharmacokinetics and safety data, scientific rationale, competitive positioning, development plan, and Phase I results.